Treating 501Mel cells with the mTOR pan-inhibitor Torin-1 (1 μM, 3 hours) resulted in increased nuclear localization of the endogenous TFEB protein, suggesting that mTOR activity contributes to the cytoplasmic retention of TFEB in melanoma cells (Fig 5A). The gene discussed is TFEB; the disease is melanoma.